Angiogenese og tumor-vaskulære interaksjoner ved endometriecancer
- Prosjektnummer
- 911327
- Ansvarlig person
- Ingunn Stefansson
- Institusjon
- Helse Bergen HF
- Prosjektkategori
- Forskerutdanning - postdoc
- Helsekategori
- Cancer
- Forskningsaktivitet
- 4. Detection and Diagnosis
Hormone receptor loss in endometrial carcinoma curettage predicts lymph node metastasis and poor outcome in prospective multicentre trial.
Eur J Cancer 2013 Nov;49(16):3431-41. Epub 2013 aug 8
PMID: 23932335
Dynamic contrast-enhanced MRI in endometrial carcinoma identifies patients at increased risk of recurrence.
Eur Radiol 2013 Oct;23(10):2916-25. Epub 2013 jun 4
PMID: 23732687
Expression of thyroid transcription factor-1 is associated with a basal-like phenotype in breast carcinomas.
Diagn Pathol 2013;8():80. Epub 2013 mai 15
PMID: 23675755
High phospho-Stathmin(Serine38) expression identifies aggressive endometrial cancer and suggests an association with PI3K inhibition.
Clin Cancer Res 2013 May 1;19(9):2331-41. Epub 2013 mar 28
PMID: 23538402
Integrated genomic analysis of the 8q24 amplification in endometrial cancers identifies ATAD2 as essential to MYC-dependent cancers.
PLoS One 2013;8(2):e54873. Epub 2013 feb 5
PMID: 23393560
Microvessel proliferation by co-expression of endothelial nestin and Ki-67 is associated with a basal-like phenotype and aggressive features in breast cancer.
Breast 2013 Jun;22(3):282-8. Epub 2012 jul 26
PMID: 22840462
Lipocalin 2 expression is associated with aggressive features of endometrial cancer.
BMC Cancer 2012;12():169. Epub 2012 mai 6
PMID: 22559235
Loss of GPER identifies new targets for therapy among a subgroup of ERa-positive endometrial cancer patients with poor outcome.
Br J Cancer 2012 May;106(10):1682-8. Epub 2012 mar 13
PMID: 22415229
Vascular proliferation is a prognostic factor in breast cancer.
Breast Cancer Res Treat 2012 Jun;133(2):501-10. Epub 2011 sep 27
PMID: 21947750
Evolution in endometrial cancer: evidence from an immunohistochemical study.
Int J Gynecol Cancer 2011 Feb;21(2):316-22.
PMID: 21734474
Stathmin overexpression identifies high-risk patients and lymph node metastasis in endometrial cancer.
Clin Cancer Res 2011 May;17(10):3368-77. Epub 2011 jan 17
PMID: 21242118
High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer.
Br J Cancer 2011 Mar;104(6):921-6. Epub 2011 feb 22
PMID: 21343929
Vascular proliferation is increased in basal-like breast cancer.
Breast Cancer Res Treat 2011 Dec;130(3):1063-71. Epub 2011 aug 28
PMID: 21874512
Stathmin is superior to AKT and phospho-AKT staining for the detection of phosphoinositide 3-kinase activation and aggressive endometrial cancer.
Histopathology 2010 Oct;57(4):641-6.
PMID: 20955391
Deoxyribonucleic acid ploidy in endometrial carcinoma: a reproducible and valid prognostic marker in a routine diagnostic setting.
Am J Obstet Gynecol 2009 Dec;201(6):603.e1-7. Epub 2009 okt 3
PMID: 19800606
Plasma calprotectin concentrations in women with endometrial carcinoma.
Gynecol Oncol 2009 Sep;114(3):491-5. Epub 2009 jul 3
PMID: 19577278
Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation.
Proc Natl Acad Sci U S A 2009 Mar;106(12):4834-9. Epub 2009 mar 4
PMID: 19261849
Expression of epidermal growth factor receptor in relation to BRCA1 status, basal-like markers and prognosis in breast cancer.
J Clin Pathol 2009 Feb;62(2):139-46. Epub 2008 aug 4
PMID: 18682421
Importance of tumour cell invasion in blood and lymphatic vasculature among patients with endometrial carcinoma.
Histopathology 2009 Jan;54(2):174-83.
PMID: 19207942
GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival.
Am J Obstet Gynecol 2008 Nov;199(5):543.e1-7. Epub 2008 jul 3
PMID: 18599012
Drug-sensitive FGFR2 mutations in endometrial carcinoma.
Proc Natl Acad Sci U S A 2008 Jun;105(25):8713-7. Epub 2008 jun 13
PMID: 18552176
Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma.
Br J Cancer 2008 May;98(10):1662-9. Epub 2008 mai 13
PMID: 18475299
HER-2/neu expression is associated with high tumor cell proliferation and aggressive phenotype in a population based patient series of endometrial carcinomas.
Int J Oncol 2008 Feb;32(2):307-16.
PMID: 18202752
Prognostic importance of vascular
APMIS,Volume 118, issue 3(Oral presentation, year meeting, The norwegian Society of Pathology, Tromsø, march 2010
Gene signatures and prognostic factors in endometrial cancer. A study with special focus on vascular invasion.
- Disputert:
- april 2011
- Hovedveileder:
- Lars Akslen
- Helga Birgitte Salvesen Medveileder
- Lars A. Akslen Hovedveileder
- Ingunn Marie Stefansson Postdoktor
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til Faglig rapportering, Helse Vest